WHO Predicts Rise in Global Cancer Rates

The World Health Organization’s (WHO) International Agency for Research on Cancer (IARC) said in a February 1 report that global cancer rates are expected to increase.

“Over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022,” the agency wrote. “The rapidly growing global cancer burden reflects both population ageing and growth, as well as changes to people’s exposure to risk factors, several of which are associated with socioeconomic development.”

The key factors behind the increase, according to the agency, are tobacco, alcohol, and obesity.

According to the report, the current leading cancers are lung, breast, colorectal, prostate, and stomach.

In July, the American Cancer Society (ACS) estimated that there would be 1,958,310 new cancer cases in the United States in 2023.

This represents a more than 11% increase from 2019, four years prior, when ACS data show there were 1,762,450 estimated cancer cases in the country.

The spike in cases from 2019 to 2023 is significant because the 2019 cancer rate only represents a 6% increase from 2015, when there were 1,658,370 estimated cases.

This means that the percent increase in cancer rate estimates in the U.S. between 2019 and 2023 is nearly double the percent increase between 2015 and 2019.

American Faith reported that the rise of over-vaccination from COVID-19 vaccines may “cause autoimmune diseases,” “promote cancer growth,” and induce heart disease, according to a study published in the journal Vaccines.

The authors warn that individuals with “genetic susceptibility, immune deficiencies, and comorbidities” are “probably the most likely to be affected.”

Florida Surgeon General Dr. Joseph Ladapo also warned that the Pfizer and Moderna COVID-19 mRNA vaccines present cancer risks.

In a press release detailing the vaccine’s safety concerns, Ladapo cited a study revealing the “presence of billions to hundreds of billions of DNA molecules per dose in the modRNA COVID-19 products tested.”

He then referred to guidance from the FDA describing how “DNA integration could theoretically impact a human’s oncogenes – the genes which can transform a healthy cell into a cancerous cell.”

The surgeon general explained that DNA integration “poses a unique and elevated risk to human health and to the integrity of the human genome,” adding, “It is my hope that, in regard to COVID-19, the FDA will one day seriously consider its regulatory responsibility to protect human health, including the integrity of the human genome.”